Učitavanje...
The Protease Inhibitors and HIV Associated Bone Loss
PURPOSE OF REVIEW: HIV infection is an established risk factor for osteoporosis and bone fracture. Combination antiretroviral therapy (cART) increases bone resorption leading to an additional 2–6% bone mineral density (BMD) loss within the first 1–2 years of therapy. While tenofovir disoproxil fumar...
Spremljeno u:
| Izdano u: | Curr Opin HIV AIDS |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4838480/ https://ncbi.nlm.nih.gov/pubmed/26918650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COH.0000000000000260 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|